•  
  • Technológia
    NGS NGS
    Microarrays Microarrays
    Real - Time PCR Real - Time PCR
    Automatizálás Automatizálás
    Bioimaging Bioimaging
  • Termékek
    Készülékek
    • NGS szekvenáló berendezések
    • Microarray berendezések
    • Automatizált pipettázó robotok
    • Automatizált mintatároló rendszerek
    • Bioimaging készülékek
    • PCR, Real-time PCR készülékek
    • NGS könyvtár preparálás
    • Nukleinsav izoláló készülékek
    • Xenium Analyzer
    Reagensek
    • NGS reagensek
    • Nukleinsav izoláló reagensek
    • PCR reagensek
    • KASP genotipizáló reagensek
    • Long-Read Technológia
    Laboratóriumi műanyag fogyóeszközök
  • Cégek
    10x GENOMICS
    Diagenode
    IAB
    Illumina
    LGC Genomics
  • Kontaktok
    Általános kapcsolatfelvétel a GeneTiCA-val GeneTiCA
    Termékfelelős Termékfelelős
    Applikációs support Applikációs support
    Technikai support Technikai support
    Automatizálás Automatizálás
  •  
    Genetica.CZGenetica.SKGenetica.HU
  •  
  •  
https://www.genetica.cz +420 272 701 055 Služeb 4 Praha

JAK SOUBORY COOKIES FUNGUJÍ?

Při návštěvě webových stránek je velmi pravděpodobné, že stránka získá nebo uloží informace ve vašem prohlížeči a to ve formě souborů cookies. Nad soubory máte plnou kontrolu, ale jsou velmi důležité pro správné fungování webu. Mohou to být informace o vašich preferencích, zájmech o produkty, přizpůsobení prostředí a chování webu. V neposlední řadě obsahují data, která využíváme pro kontinuální zlepšování webu a našich služeb. Stále respektujeme vaše právo na soukromí, a proto se můžete rozhodnout, že se sběrem souborů cookies nebudete souhlasit.Nezapomínejte na to, že blokování některých souborů cookies můžete ovlivnit, jak stránka funguje a jaké služby jsou vám nabízeny.


GeneTiCA Hungary Kft. - főoldal

Illumina launches new software to enable tertiary analysis for oncology applications, and soon rare disease

Read more
Banner 1
Banner 2
Banner 3

Hírek

29. 03. 2023 - VIDEO: What is homologous recombination deficiency (HRD)?
27. 03. 2023 - Using Single-Cell Sequencing to Investigate Murine COVID-19 Mortality
20. 03. 2023 - Illumina launches its first product enabling long- and short-read sequencing on one instrument
15. 03. 2023 - Children’s Mercy Kansas City tackles the unique complexity of pediatric cancer
13. 03. 2023 - Introducing the NovaSeq X and X Plus Sequencing Systems
13. 03. 2023 - Working to solve rare disease and support patients
07. 03. 2023 - Using whole-genome sequencing to study early-onset Parkinson’s disease
06. 03. 2023 - Illumina and Myriad Genetics expand partnership to broaden access to HRD testing in the United States
27. 02. 2023 - Find the next breakthrough cancer therapeutic with Visium
20. 02. 2023 - WEBINAR: Whole-Genome Sequencing and the way forward for Paediatrics
15. 02. 2023 - WEBINAR: NGS-Based Homologous Recombination Deficiency Assessment with a Semi-Automated Protocol
15. 02. 2023 - Illumina delivers first NovaSeq X Plus sequencer to the Broad Institute
14. 02. 2023 - Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2022
13. 02. 2023 - How organizations around the world are closing the cancer care gap
09. 02. 2023 - WEBINAR: Respiratory Pathogen ID and AMR Panel – A precision metagenomics solution for respiratory pathogen identification
08. 02. 2023 - Illumina Appoints Joydeep Goswami Chief Financial Officer
07. 02. 2023 - VIDEO: UK Festival of Genomics & Biodata inspires and connects industry leaders
01. 02. 2023 - WEBINAR: Multiomic profiling of patient-derived subclones identifies aggressive cellular subpopulations in paediatric diffuse high-grade gliomas
31. 01. 2023 - Sequencing within reach, for any application
26. 01. 2023 - WEBINAR: Empower murine studies to accelerate cancer research
17. 01. 2023 - Illumina to Announce Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 7, 2023
16. 01. 2023 - Meet NovaSeq X Series
16. 01. 2023 - Illumina and Nashville Biosciences Announce Sequencing Agreement with Amgen
12. 01. 2023 - Does Your Dog Have Nine Lives, Too? This DNA Test Can Tell You
10. 01. 2023 - WEBINAR: Clonal evolution in breast cancer: application of ultra-deep single cell multiomic sequencing
09. 01. 2023 - Experts in Hungary and the Czech Republic share their experiences using Comprehensive Genomic Profiling
02. 01. 2023 - Illumina Ranks Among Top Scores on Dow Jones Sustainability Index and CDP
22. 12. 2022 - The Next Frontier in Carbon Capture is a Hungry Bacterium
15. 12. 2022 - WEBINAR: A multi-species, low-cost, genome-wide genotyping platform to support molecular breeding in small grains
06. 12. 2022 - Addressing the Shortage of Genetic Counselors with Software
28. 11. 2022 - WEBINAR: Shining a Light on Rare Disease
22. 11. 2022 - Addressing the Shortage of Genetic Counselors with Software
21. 11. 2022 - RNA Sequencing Critical to Identifying Key Fusions for Oncology Patients
14. 11. 2022 - Greenwood Genetic Center: Answering the Unanswered
08. 11. 2022 - Can Genomics Stop the World’s Leading Cause of Death?
31. 10. 2022 - WEBINAR: Xenium In Situ - Welcome to the revolution
20. 10. 2022 - WEBINAR: Resolving tumor microenvironment heterogeneity at the single cell level from fixed samples
17. 10. 2022 - Illumina Unveils Revolutionary NovaSeq X Series to Rapidly Accelerate Genomic Discoveries and Improve Human He
10. 10. 2022 - Illumina Introduces Multiple Breakthrough Sequencing Innovations at Inaugural Genomics Forum
03. 10. 2022 - The Illumina Innovation Roadmap: Empowering Genomic Breakthroughs
26. 09. 2022 - Illumina Genomics Forum to Convene Leading Visionaries to Explore Architecting Health's Radically New Infrastr
19. 09. 2022 - Illumina Genomics Forum
12. 09. 2022 - WEBINAR: An Introduction to Sequencing
06. 09. 2022 - WEBINAR: Where do I begin with IVDR? Illumina - The basics, the transition and how we can help
31. 08. 2022 - WEBINAR: Metatranscriptomic Analysis of the Skin and Gut Microbiomes of an Isolated Amazonian Community
29. 08. 2022 - 50 Patents in 25 Years: A Look Back on the Sequence of Dr. Colin Barnes’s Career
22. 08. 2022 - Illumina Genomics Forum to Feature Bill Gates and Distinguished Health Leaders Addressing Need for Global Acce
16. 08. 2022 - Illumina Unveils its Most Accurate and Comprehensive Secondary Analysis Platform
08. 08. 2022 - The Soil Secrets That Could Help Feed the World
04. 08. 2022 - Inaugural Illumina Genomics Forum with a Conversation with Former U.S. President Barack Obama
26. 07. 2022 - Illumina Invests in £30M Venture Fund to Advance Breakthroughs in Human Health
19. 07. 2022 - Illumina Research Test Codeveloped with Merck to Unlock Deeper Insights into the Tumor Genome
12. 07. 2022 - Australia’s PrOSPeCT Project Is Sequencing Thousands of Cancer Patients
04. 07. 2022 - AI Drives Data Insights for Doctors and their Patients
27. 06. 2022 - Video: European Customers Share Their Success Stories
20. 06. 2022 - “All Patients Should Have Their Tumor Sequenced At Least Once”
15. 06. 2022 - WEBINAR: Single-cell transcriptomic landscape in Alzheimer’s disease
06. 06. 2022 - Illumina Introduces New Pan-Cancer Companion Diagnostic to Match Patients to Targeted Therapy
31. 05. 2022 - Baby Fitz’s Life-Saving Diagnosis Through Whole-Genome Sequencing
23. 05. 2022 - WEBINAR: A comprehensive solution for virtually any application: NextSeq 1000 and 2000
16. 05. 2022 - 1st 10x Genomics Experience Meeting 2022
09. 05. 2022 - WEBINAR: Introducing Illumina Infinity long read technology
02. 05. 2022 - WEBINAR: Advancements in translational biomarker identification from cell-free RNA
25. 04. 2022 - WEBINAR: Can genomic surveillance detect the next pandemic before it’s too late?
14. 04. 2022 - For Kidney Transplant Recipients, a More Accurate and Tailored Care Plan
07. 04. 2022 - Can Wastewater Surveillance Protect Public Health?
30. 03. 2022 - WEBINAR: Enabling in-house comprehensive genomic profiling for today's and tomorrow's clinical needs
28. 03. 2022 - WEBINAR: Illumina VIP Event
21. 03. 2022 - WEBINAR: Spatiotemporal analysis of cardiac tissue during myocardial infarction
14. 03. 2022 - Scaling to the cloud to support whole-genome sequencing
08. 03. 2022 - Skis, Skincare, and More: Making Better Products with Algae
21. 02. 2022 - From Patents to Patients: Meet the Women Making a Difference at Illumina
14. 02. 2022 - Patient Success Story: Beating Stage IV Lung Cancer
07. 02. 2022 - Illumina and Boehringer Ingelheim Announce Companion Diagnostic Partnership
01. 02. 2022 - Let it Grow: A DNA Database for Plants, One Species at a Time
26. 01. 2022 - 2021 in Genomics
18. 01. 2022 - Laboratóriumi folyadékkezelő automatizálási megoldások
18. 11. 2020 - WEBINAR for ALL: Single cell sequencing and spatial transcriptomics - Nov. 23-rd, 14:00
04. 11. 2020 - Az Illumina 2020 őszi virtuális eseményei !
27. 10. 2020 - ASHG’s Annual Meeting Goes Virtual
22. 10. 2020 - Delivering high-confidence DNA variant, RNA fusion and TMB data
15. 10. 2020 - Exploring Immunity—Linking Highly Multiplexed Antigen Recognition to Immune Repertoire and Phenotype
25. 09. 2020 - Using Single-Cell Multiomics to Reveal New Insights into Uveal Melanoma Evolution
22. 09. 2020 - Oncology variant interpretation just got more precise
23. 01. 2017 - Illumina - Egy új korszak kezdete a szekvenálásban!
Banner 4
Banner 5
illumina3.png IAB.png 10xGenomics_firma.jpg diagenode_logo1.png LCG_315x78px.png
Copyright © 2023 GeneTiCA Kft. +36 244 06 607 | genetica@genetica.hu